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Abstract
Background and objectives: The cost of  medical care and availability of  resources (human and facilities) which differs 
from nation to nation are amongst others, factors driving medical tourism (MT) despite its potential drawbacks. The aim of  
the study was to analyse all patients that presented with neurosurgical complications following MT.
Methods:  A  single  institution  prospective  study  was  carried  out.  Data  which  included patients’   demographics,   di-
agnosis,   Glasgow   coma   scale  score  at  admission,   type  of  complication,    and   outcome   were   collected   over   a 
3   year   period   and   analysed.
Results: A total of  23 neurosurgical cases were seen during the study period with a median age of  42 years (17-70 years). 
India is the most common country visited by Nigerian patients. Nine patients died from various complications on arrival in 
Nigeria. There was no significant statistical  difference  between  the  outcome  and  patients  clinical  status  prior  to  travel 
(p=0.107),  country  where  the  surgery  was  done  (p=0.776),  admission  GCS  in  Nigeria (p=0.169), and redo surgery 
in Nigeria (0.181).
Conclusion: Government in different nations should have legislations to ensure that medical tourists' receive appropriate 
care abroad, proper follow-up care upon their return, and also promulgate  laws  to  regulate  quasi  and  organised  MT 
agencies  that  are  operating  in  a regulatory vacuum.
Keywords: Medical tourism, Morbidity, Mortality
DOI: http://dx.doi.org/10.4314/ahs.v15i1.31
Introduction
The price tag on medical care and availability of  re-
sources (human and facilities) differs from nation  to 
nation.  These  amongst  others  have  been  one  of  
the  dynamics  driving  medical tourism (MT) despite its 
potential drawback and perils.
Medical  tourism  involves  patients  leaving  their  home 
country  to  access  non-emergent medical care, often 
surgery1,2. It is generally portrayed as a potential solu-
tion to a wide range of  clinical conditions  encumbering 
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solution   to   dearth   of    facilities   or   skilful   per-
sonnel,   delay   in   surgical   intervention,prohibitively 
expensive medical care and offering of  treatment that 
may be illegitimate in a patients home country3,4.
In times past, hospital facilities in high-income coun-
tries marketed health services usually to the global elite 
of  other countries5,6; neurosurgical cases being among 
the common diseases. However, in recent times, hospi-
tals positioning themselves as leading medical tourism 
(MT) destinations are largely found within lower and 
middle income countries. In these hospitals, favourable 
exchange rates is presently giving them a competitive 
advantage especially among price-conscious interna-
tional patients3,7. Governments and private organiza-
tions in these countries are also helping in promoting 
the MT industry8.
The concept of  MT is a rapidly developing phenome-
non with policy implication for health systems. Growth 
in the popularity of  MT has resulted in an of  increase 
attention being given to it from researchers, policy-mak-
ers, and the media. Irrespective of  the precise growth 
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rate, it is  generally  agreed  that  the  MT  industry  is 
growing  rapidly  in  many  Asian  and  South American 
nations, and is poised for additional growth in countries 
with the necessary human and technical resources3,9. 
The industry is a highly profitable source of  hard cur-
rency for host countries and a net loss of  capital to de-
parture countries. Arguably though, this is perhaps one 
of  the most prominent factors driving medical tourism 
(MT) despite its potential drawback and perils.
Worthy  of   note  is  that  MT  can  be  extremely  dan-
gerous  with  fatal  consequences  to  the medical tourist. 
As we know, even the slightest neurosurgical gaffe can 
be fatal. There are several  draw back associated  with 
medical  tourism  that are not usually  well thought-out.
Health care regulation standard varies from nation to 
nation and quite a number do not have rigorous checks 
and balances on what medical professionals need to do 
to get certified and to keep  practicing.  Secondly,  pa-
tients  may  get  drawn  in  by  the  possibility  of  a  low 
cost procedure  but  end  up  paying  far  more as  the 
patient  is  yet  to  be  properly  clerked  and investigated; 
they  may  even  be  managed  by  inappropriate  medical 
personnel  or  have unsuitable surgical procedures. Be-
sides, the patient sacrifices his or her familiarity, loss of
continuity of  professional care and probably loose sig-
nificant if  not all legal guarantees by going  for  health 
care  beyond  their  border;  it  will  be  quite  demanding 
if   not  mission impossible to seek damages in case of  
negligence or incompetence. In addition, the spread of
infectious diseases across national borders remains a 
probable risk. Given its positive and negative effects on 
the health care systems of  departure and destination 
countries, medical tourism is a highly significant and 
contested phenomenon2.
Globally,  there  are  limited  data  on  clinical  outcomes 
associated  with  MT  especially  in departure  third 
world countries;  and there is currently few data on the 
impact of  MT on patients. In Nigeria, the MT industry 
is more or less quasi with various registered and un-
registered  agencies,  and  persons  assisting  patients 
to  access  non-emergent  and  even emergent medical 
care abroad. This has since taken a quantum leap in re-
cent years in the country. A lack of  reliable data about 
MT makes it difficult to create health system policy, and 
public health responses to address the associated risks 
and shortcomings, such as spread of  infectious diseas-
es, amongst others, associated with this industry. Yet, 
there has been little effort to systematically synthesize 
what is known about the effects of  this phenomenon.
The aim of  our study is to analyse all patients that pre-
sented with neurosurgical complications following MT.
Patients and method
The series consisted of  a prospective study of  all pa-
tients that presented at our centre after having surgery 
at an outside facility outside our national boundary. The 
data was collected over a 3 year period, January 2011 to 
December 2013.
A detailed clinical history and physical examination 
was done in all the cases. Cranial and or spinal com-
puted  tomographic  scan with a cranial/spinal  mag-
netic  resonance  imaging  was done in all the index 
patients with additional investigations as required. The 
data documented included patients demographics, 
clinical status prior to travel for surgery abroad (emer-
gent or non-emergent),  diagnosis  (prior to travelling 
and on presenting to us), region of  the body involved 
(Cranial or spinal), country where procedure was done, 
medical report from MT centre, Glasgow coma scale 
(GCS) score on admission, and outcome (dead or alive). 
Complications were characterized as lethal (mortality), 
causing new permanent deficits (permanent morbidi-
ty), causing new transient deficits (transient morbidity). 
Analysis of  the variables  was  by  simple  proportion 
and  percentages.  Fischer’s  exact  test  was  used  to 
determine  the differences  between  group  means.  A 
probability  (p) of  less than 0.05  was considered statis-
tically significant.
Results: 
A total of  23 neurosurgical cases were seen during the 
study period. Of  these cases, 13 were males. The me-
dian age was 42 years (17-70 years). The indication for 
MT was due to intracranial lesions in 10 patients (7 
males, 3 females) and spinal diseases in 13 individuals
(6 males, 7 females). The most visited country was India 
(17 cases, 73.9%) (Figure 1). 
African Health Sciences Vol 15 Issue 1, March 2015


























    



















*UAE= United Arab Emirates
Figure 1. Countries visited by the patients for medical tourism 
All the patients travelled by air lasting at least 6 hours, 
except one patient that travelled by road to Ghana (7 
hours journey). All the patients that travelled by air used 
commercial airlines even for that had emergent clinical 
issues like complete cervical spine injury. The clinical 
status of  the patient was emergent in 8 of  the 23 pa-
tients. The GCS was 15 in 18 patients (78%) when they 
presented to us (Table 1). 
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*GCS-  Glasgow  coma  score,  PM-  Permanent  new  morbidity,  TM-  Temporary  new morbidity 
Two patients had wrong level surgery and the most 
common complication was infection (6 patients, 26%). 
Nine patients died from their complication after re-pre-
senting in Nigeria (Table 2), a third of  which was ac-
counted for by septicaemia.
There was no significant  statistical difference  between 
the outcome and gender, region of  lesion, patients clin-
ical status prior to travel (need  emergent or nonemer-
gent  intervention) (Table  2),  country  where  the  sur-
gery  was  done  (p=0.776),  admission  GCS  in  Nigeria
(p=0.169), and redo surgery (p=0.181).
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Table 1: Summary of all patients
Table 2. Outcome of patients related to gender, region of surgery and  
pre-operative clinical status of patients 
 
                                 Died    Permanent deficit    Transient deficit   p-value 
  Gender 
Male                         6                   1                             6 
Female                      3                   2                             5                  0.589 
Pre-operative status 
Emergent                  5                    0                            3 
Non-emergent           4                    3                            8                 0.107 
Location of lesion 
Intracranial                4                    1                             5 




Medical tourism has being in practice since the 18th and 
19th centuries, when people travelled to spas to “take 
the waters” as a means of  improving their health; like-
wise people in remote settlements and less developed 
countries, have always travelled to reach clinics or physi-
cians for aid10,11. However in the last two decades, there 
have been an extensive denationalization and marketi-
zation of  health care globally (developing and in devel-
oped countries)9.
The fact that people are able and willing to travel long 
distances, even to developing nations, for cheaper-cost 
health care suggests that health care in the developed 
countries has become too  expensive  or too  inacces-
sible  for many  people10-12.  Third  world  countries 
commonly visited  by  patients  for  health  care  include 
India,  Malaysia,  Singapore,  and  Thailand.  In Nigeria, 
India is the leading country that patients travel to for 
medical procedures. Almost three-quarters of  our pa-
tients in this study had visited India. 
 
Medical  tourists  are  at  risk  for  hospital  infection, 
acquired  and  nosocomial13.   These pathogens  which 
they  may  import  to  their  country  may  be  rare  and 
it  may  even  be  a multidrug  resistant  strain.  The 
most  common  reason  for  presenting  to  our  facility 
was infection (26%). A third of  the 9 patients that died 
had septicaemia.
In study from the United Kingdom (UK), it was noted 
that the UK is a clear net exporter of  medical travellers. 
In 2010, an estimated 63,000 UK residents travelled for 
treatment, while around 52,000 patients sought treat-
ment in the UK14. However in Nigeria, there is no re-
liable data on patient numbers, flows, treatment types 
and success rates. Success rates are generally reported 
by some patients, relations, news media and quasi agen-
cies without an independent auditor or the inclusion of  
long-term success rates after medical tourists return to 
their home countries.  These success rates are at best 
notional.  In addition,  a lack of  dependable  data about 
MT makes it difficult to create policy to improve pa-
tient safety measures or guide the development of  the 
industry in an equitable and ethical manner, to improve 
our local health system,   and   publicize   public   health 
responses   to   address   the   associated   risks   and 
shortcomings associated with this industry (e.g. spread 
of  infectious diseases).
Two  of  our  patients  had wrong  level  surgery  while 
one  had retained  gauze  that  lead  to septicaemia from 
which she died from. None of  this patient could have 
a legal redress. In the literature there is no substantial 
proof  to suggest negligent issues amongst MT bro-
kerages. Despite this, the obvious regulatory vacuums 
around MT services leaves room for hazardous medical 
and business practices; hence the need to proactively 
manage MT. At present MT should be viewed as an 
unbalanced trade practice.
Despite  the rapid expansion  of  the MT industry,  few 
standards  exist to ensure that these businesses organ-
ize high-quality, competent international health care. In 
Nigeria, many quasi MT companies are now involved in 
organizing cross-border health services. Most of  these 
personnel  are  not  trained  nor  are  they  familiar 
with  applicable  statute,  case  law  and professional 
standards  in  the  countries  where  health  services  are 
offered.  There  are  no regulatory criteria intended to 
protect the health and financial interests of  patients.
Although  this study did not find any statistically  sig-
nificant  association  between  patients’ outcome and 
country visited for treatment. Nigeria and other devel-
oping countries have the obligation to implement pub-
lic policies to moderate the demand for MT by their 
populaces. A call for a comprehensive public health re-
sponse to MT and its effects should be coupled with 
a clear understanding that medical tourism is a highly 
diverse practice.
There is need for research to produce dependable un-
derstandings about the scope and volume of  the prac-
tice of  MT in a way that is comparable across facilities 
and countries. This may also offer insights into impor-
tant differences between medical tourists based on de-
mographic factors, patients’ health status, etc.
Since there is an increasing numbers of  patients trav-
elling in search of  medical care beyond their nation-
al boundaries despite its associated risks, Government 
ministries in all nations from which patients depart for 
care abroad should have legislations to ensure that med-
ical tourists'  receive  appropriate  care  abroad,  proper 
follow-up  care  upon  their  return,  and promulgate 
laws to help in regulating most of  the quasi and or-
ganised MT agencies that are operating in a regulatory 
vacuum.
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